Blood sugar levels indicative of β-cell dysfunction in patients with type 2 diabetes: Study
USA: Blood sugar levels in adults with type 2 diabetes (T2D) treated with metformin alone, is strongly associated β-cell dysfunction, finds a recent study in the Journal of Diabetes and its Complications. This implies that efforts for glycemia improvement should focus on interventions to improve β-cell function.
Kristina M. Utzschneidera, University of Washington, Seattle, WA, USA, and colleagues aimed to evaluate the relationship between measures of glycemia with β-cell function and insulin sensitivity in adults with early type 2 diabetes.
For the purpose, the researchers assessed baseline data from 3108 adults with T2DM <10 years treated with metformin alone enrolled in the Glycemia Reduction Approaches in Diabetes.
A Comparative Effectiveness (GRADE) Study -- Using oral glucose tolerance tests, insulin and C-peptide responses and insulin sensitivity were calculated. Regression models evaluated the relationships between glycemic measures (HbA1c, fasting and 2-h glucose), measures of β-cell function and insulin sensitivity.
Key findings of the study include:
- Insulin and C-peptide responses were inversely associated with insulin sensitivity.
- Glycemic measures were inversely associated with insulin and C-peptide responses adjusted for insulin sensitivity.
- HbA1c demonstrated modest associations with β-cell function (range: r − 0.22 to −0.35).
- Fasting and 2-h glucose were associated with early insulin and C-peptide responses (range: r − 0.37 to −0.40) as well as late insulin and total insulin and C-peptide responses (range: r − 0.50 to −0.60).
"Glycemia correlates more strongly with β-cell dysfunction than insulin resistance," wrote the authors.
"Glycemia is strongly associated with β-cell dysfunction in adults with early T2DM treated with metformin alone," they concluded. "Efforts to improve glycemia should focus on interventions aimed at improving β-cell function."
Reference:
The study titled, "Association of glycemia with insulin sensitivity and β-cell function in adults with early type 2 diabetes on metformin alone," is published in the Journal of Diabetes and its Complications.
DOI: https://www.sciencedirect.com/science/article/abs/pii/S1056872721000866
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.